/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

Akanda Corp

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$0.998 0(0%) AKAN at 04 Dec 2025 04:25 PM Drug Manufacturers - Specialty & Generic
Lowest Today 0.98
Highest Today 1.0307
Today’s Open 1.01
Prev. Close 1.01
52 Week High 5.94
52 Week Low 0.88
Day’s Range: Low 0.98 High 1.0307
52-Week Range: Low 0.88 High 5.94
1 day return -
1 Week return -3.92
1 month return -33.33
3 month return -71.75
6 month return -30.98
1 year return -39.5
3 year return -98.84
5 year return -
10 year return -

Institutional Holdings

UBS Group AG 0.85

XTX Topco Ltd 0.47

Tower Research Capital LLC 0.00

SBI Securities Co Ltd 0.00

Blackstone Alternative Multi-Strategy I 0.00

Market Status

Fundamentals

Market Cap 0.74 M

PB Ratio 0.2131

PE Ratio 0.0312

Enterprise Value -1.43 M

Total Assets 7.91 M

Volume 151166

Company Financials

Annual Revenue FY23:2160052 2.2M, FY22:2619682 2.6M, FY21:41431 0.0M, FY20:2062 0.0M, FY19:0 0.0M

Annual Profit FY23:-6427777 -6.4M, FY22:3269559 3.3M, FY21:-714726 -0.7M, FY20:253 0.0M, FY19:0 0.0M

Annual Net worth FY23:-32275070 -32.3M, FY22:397045 0.4M, FY21:-9224132 -9.2M, FY20:-2945971 -2.9M, FY19:-1888448 -1.9M

Quarterly Revenue Q1/2025:359658 0.4M, Q3/2024:477006 0.5M, Q1/2024:762608 0.8M, Q3/2023:381304 0.4M, Q2/2023:1397443 1.4M

Quarterly Profit Q1/2025:347630 0.3M, Q3/2024:-139248 -0.1M, Q1/2024:-823960 -0.8M, Q3/2023:-411980 -0.4M, Q2/2023:-2765108 -2.8M

Quarterly Net worth Q1/2025:-1413139 -1.4M, Q3/2024:-2682890 -2.7M, Q1/2024:-26397188 -26.4M, Q3/2023:-13198594 -13.2M, Q2/2023:-5877882 -5.9M

Fund house & investment objective

Company Information As of August 21, 2025, Akanda Corp. was acquired by First Towers & Fiber Corp., in a reverse merger transaction. Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis-based products. The company was incorporated in 2021 and is headquartered in Toronto, Canada.

Organisation Drug Manufacturers - Specialty & Generic

Employees 0

Industry Drug Manufacturers - Specialty & Generic

CEO Ms. Katharyn Field

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow